Pharma sector continues to thrive, driven by price-led expansion

The Indian pharmaceutical market demonstrated robust growth in April 2025, achieving a 7.8% annual increase, fueled by price adjustments and new product introductions. Sales reached Rs 19,711 crore, with cardiac, neuro/CNS, and anti-neoplastics segments significantly contributing to this expansion. Despite modest volume growth, effective pricing strategies and demand in chronic and acute care drove the industry’s success.